Article Text

PDF
Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn’s disease
  1. S Joossens1,
  2. M Pierik1,
  3. A Rector2,
  4. S Vermeire3,
  5. M V Ranst4,
  6. P Rutgeerts5,
  7. X Bossuyt6
  1. 1Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
  2. 2Laboratory of Clinical and Epidemiological Virology, University Hospital Gasthuisberg, Leuven, Belgium
  3. 3Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
  4. 4Laboratory of Clinical and Epidemiological Virology, University Hospital Gasthuisberg, Leuven, Belgium
  5. 5Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
  6. 6Laboratory of Medicine, University Hospital Gasthuisberg, Leuven, Belgium
  1. Correspondence to:
    Dr S Joossens
    Department of Gastroenterology, University Hospital, Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium; sofie.joossens{at}uz.kuleuven.ac.be

Statistics from Altmetric.com

Recently, an association between the presence of antibodies to Saccharomyces cerevisiae (ASCA) and mutations in exon 1 and the promoter region of the mannan binding lectin (MBL) gene was described in 58 patients with Crohn’s disease (CD).1 A possible link between ASCA and MBL mutations in patients with CD is plausible. MBL is a component of the innate immune system that can bind to S cerevisiae and the serum concentration of MBL …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.